Type 2 diabetes is a chronic condition in which an individual is unable to produce or use insulin well, that subsequently results in elevated blood sugar. This can result in blindness, stroke, heart disease, amputations amongst others. Beyond the mandate to eat well and exercise, diabetes patients must test their blood several times per day and also self-administer insulin based injections which helps to calculate their blood glucose levels, the amount of carbohydrates they can consume and in what amount they can physically exert themselves. The incorporation of artificial intelligence in diabetes management market has opened up new avenues in the field of healthcare, which in turn promises to be a considerable development in the domain.
The concerns about high rate of type 2 diabetes complications indulged the medical researchers from St. Marcarius-Alexandria University Hospital to develop a solution which makes diabetic care easier, accessible and holistic in nature. An application named Charlie was the result. The app’s algorithm helps in calculating the insulin type and optimal level for each user. Charlie tends to make the entire process more efficient and effective in nature, providing them with a precise dosage calculation. This calculation in turn accounts for blood glucose levels, lifestyle data, and preexisting healthcare conditions of an individual. Charlie also contained a forum for information sharing and social networking. Charlie passed through the university IRB process as it provided substantial improvement in diabetes care with minimal risk. Also, the application upon IRB approval generated positive results in a clinical trial at University Hospital. Also, this was a breakthrough in the overall industry, all the individual groups did not experience the same results such that racial minorities did not experience positive results as while users.
“A remarkable change or an existing makeover? Though a lot of existing makeovers are happening currently in this field, but how much they can certainly impact the diabetes sector is still a question mark. Clinical trials and researchers are trying their best to come up with a solution that can positively impact the diabetes domain in general but a solution that can effectively cater to real time consumer needs is still under trial phase. As we move towards a digitalized society in near future, we aim to build an application that can instantly meet needs of a diabetic patient in one go.’’
United States Artificial Intelligence in Diabetes Management Market Revenue, By End User (2018)
The detailed research study provides qualitative and quantitative analysis of the global artificial intelligence in diabetes management market. The market has been analyzed from demand as well as supply side. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
Some of the major players operating in the global artificial intelligence in diabetes management market are Livongo Health, medicsen, Medtronic, PredictBGL, Sensyne Health plc., Apple Inc., Diabnext, DreaMed Diabetes, Ltd., Glooko Inc., GlucoMe, Google Inc., Hedia, IBM Corporation, Sweetch, TypeZero Technologies, Inc., Virta Health Corp, Wellthy Therapeutics Pvt Ltd, XBIRD among others.
By End User